or Try an Advanced Search...

    Antacid Stocks List

    Symbol Grade Name % Change
    PBH A Prestige Brand Holdings, Inc. 0.85
    ANIP C ANI Pharmaceuticals, Inc. -1.92
    GSK F GlaxoSmithKline PLC -1.15
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Distribution
    Related Stock Lists: Acid Cough Medicine Oral Care Products Pharmaceutical Abrasives Antibiotics Antiemetics Asthma Body Care Products Cancer Chloroarenes Cleaning Cleaning Agent Cleaning Products Consumer Health Products Contract Manufacturing Contract Manufacturing Services Depression Dermatology

    Related ETFs - A few ETFs which own one or more of the above listed Antacid stocks.

    Symbol Grade Name Weight
    PJP C PowerShares Dynamic Pharmaceuticals 6.49
    PPH D Market Vectors Pharmaceutical ETF 4.02
    XPH B SPDR S&P Pharmaceuticals ETF 3.84
    PSCH B PowerShares S&P SmallCap Health Care Portfolio 3.13
    PILL B Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 2.63
    View all Antacid ETFs...
    Compare ETFs
    Compare PJP to PILL Compare PJP to PPH Compare PJP to PSCH

        Antacid Stocks Recent News

        Date Stock Title
        Nov 13 GSK Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
        Nov 13 GSK Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
        Nov 12 GSK GSK lowered to hold by Jefferies, valuation disconnect cited
        Nov 10 ANIP ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 9 ANIP ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
        Nov 9 ANIP ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript
        Nov 8 ANIP Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics
        Nov 8 ANIP ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates
        Nov 8 ANIP ANI: Q3 Earnings Snapshot
        Nov 8 ANIP ANI Pharmaceuticals Non-GAAP EPS of $1.34 beats by $0.25, revenue of $148.33M beats by $3.96M
        Nov 8 ANIP ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
        Nov 8 GSK AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
        Nov 8 PBH Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Highlights: Navigating Supply ...
        Nov 7 GSK Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
        Nov 7 ANIP ANI Pharmaceuticals Q3 2024 Earnings Preview
        Nov 7 GSK Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'
        Nov 7 PBH Prestige Consumer Healthcare Non-GAAP EPS of $1.09 beats by $0.01, revenue of $283.8M beats by $0.98M
        Nov 7 PBH Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
        Nov 7 PBH Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 100% Above Its Share Price
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Distribution
        Related Stock Lists: Acid Cough Medicine Oral Care Products Pharmaceutical Abrasives Antibiotics Antiemetics Asthma Body Care Products Cancer Chloroarenes Cleaning Cleaning Agent Cleaning Products Consumer Health Products Contract Manufacturing Contract Manufacturing Services Depression Dermatology
        Antacid

        An antacid is a substance which neutralizes stomach acidity and is used to relieve heartburn, indigestion or an upset stomach. Some antacids have been used in the treatment of constipation and diarrhea. Currently marketed antacids contain salts of aluminum, calcium, magnesium, or sodium. Some preparations contain a combination of two salts, such as magnesium carbonate and aluminum hydroxide.

        More about Antacid
        Browse All Tags